Related Experiment Video
Updated: Mar 25, 2026

07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
1.3K
Experimental Repression Targeting Long Noncoding RNAs (lncRNAs) Using an Antisense Oligonucleotide (ASO) Technology
Chloé Loyer1,2,3, Tatiana Vinasco-Sandoval1,2,3, Juliette Montanari1,2,3
1Université Paris-Saclay, Gif-sur-Yvette, France.
Methods in Molecular Biology (Clifton, N.J.)
|March 24, 2026
Summary
Long noncoding RNAs (lncRNAs) are crucial for skin cell regulation. This study optimized antisense oligonucleotides (ASOs) for efficient lncRNA knockdown in epidermal keratinocytes, advancing skin biology research.
Area of Science:
- Dermatology and Molecular Biology
- Epigenetics and Gene Regulation
- Transcriptomics and RNA Biology
Background:
- Epidermal keratinocytes maintain skin homeostasis through proliferation and differentiation.
- Long noncoding RNAs (lncRNAs) significantly influence gene expression and cell fate but are poorly understood.
- Existing methods for studying lncRNA function have limitations in efficiency and specificity.
Purpose of the Study:
- To develop and optimize a protocol for efficient antisense oligonucleotide (ASO) delivery into primary human epidermal keratinocytes.
- To establish a reliable method for investigating the functional roles of nuclear lncRNAs in epidermal biology.
- To demonstrate the utility of ASOs for transcript-specific knockdown of lncRNAs in keratinocytes.
Main Methods:
- Optimization of antisense oligonucleotide (ASO) transfection protocols for primary human epidermal keratinocytes.
- Utilizing RNase H-mediated degradation for targeted transcript knockdown.
- Quantifying lncRNA expression levels using droplet digital PCR (ddPCR).
- Proof-of-concept knockdown of the lncRNA LINC02154 using three distinct ASOs.
Main Results:
- An optimized ASO transfection protocol was established for efficient lncRNA knockdown in epidermal keratinocytes.
- The ddPCR method provided accurate quantification of transcript expression levels post-knockdown.
- Successful repression of LINC02154 expression was achieved using ASOs, validating the approach.
Conclusions:
- ASO-mediated knockdown is a powerful and versatile tool for functional studies of nuclear lncRNAs in epidermal keratinocytes.
- This methodology facilitates a deeper understanding of lncRNA-mediated gene regulation in skin cell fate.
- The optimized protocol provides a reliable platform for advancing research in epidermal biology and skin homeostasis.
Related Concept Videos
Experimental RNAi
8.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
Types of RNA
16.2K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
16.2K
RNA Interference
28.6K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.6K
siRNA - Small Interfering RNAs
19.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K
lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
Eukaryotic Transcription Inhibitors
11.3K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.3K

